Company news

Pharming Group NV news in 2025

Pharming Group NV's news releases, calls and decks from 2025, newest first.

View company

Pharming Group to participate in Oppenheimer Movers in Rare Disease Summit

December 8, 2025

Pharming Group reports third quarter 2025 financial results with significant growth in revenue, profitability and cash flow

November 6, 2025

Pharming Group to participate in Fireside Chat at Jefferies Global Healthcare Conference in London

October 30, 2025

Pharming Group to report third quarter 2025 financial results and provide business update on November 6

October 23, 2025

Pharming Group announces presentations at 2025 ACAAI Annual Scientific Meeting showcasing new data across rare disease portfolio

October 20, 2025

Pharming Group provides update on previously announced G&A expense reduction plan

October 6, 2025

Pharming Group announces U.S. FDA acceptance and Priority Review of supplemental New Drug Application for leniolisib in children with APDS aged 4 to 11 years

October 1, 2025

Neumirna Therapeutics Appoints Ellen K. Donnelly as Chief Executive Officer

September 18, 2025

Pharming Group promoted to the Euronext AMX® index

September 10, 2025

Pharming Group to present at the H.C. Wainwright 27th Annual Global Investment Conference

September 3, 2025

Pharming Group appoints Kenneth Lynard as Chief Financial Officer

September 2, 2025

Pharming Group to participate in August investor conference

August 4, 2025

Pharming Group reports second quarter and first half 2025 financial results and provides business update

July 31, 2025

Pharming Group to report second quarter and first half 2025 financial results and provide business update on July 31

July 17, 2025

Pharming Group to host webcast on findings of a new study published in Cell advancing functional classification of variants of uncertain significance (VUS) to improve APDS diagnosis

June 24, 2025

Pharming Group reports on results of the 2025 Annual General Meeting of Shareholders

June 11, 2025

Pharming Group to participate in June investor conferences

May 28, 2025

Pharming Group reports first quarter 2025 financial results and provides business update

May 8, 2025

Pharming Group announces the 2025 Annual General Meeting of Shareholders and the nomination of a new Non-Executive Director

April 30, 2025

Pharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical Immunology Society (CIS)

April 25, 2025

Pharming Group to report first quarter 2025 financial results on May 8

April 24, 2025

Pharming receives positive recommendation from NICE for Joenja®▼(leniolisib) as a treatment for APDS

April 23, 2025

Calls in 2025

Decks in 2025